Ray Dalio Amgen Inc Transaction History

Bridgewater Associates, LP

$23.8 Billion
Q3 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Amgen Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 11,295 shares of AMGN stock, worth $3.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,295

Previous 7,435 51.92%

Holding current value

$3.86 Million

Previous $2.08 Million 53.59%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$271.18 - $309.22 $1.05 Million - $1.19 Million	3,860 Added 51.92%	11,295 $3.19 Million
Q2 2025 Aug 13, 2025	BUY	$262.28 - $309.85 $1.95 Million - $2.3 Million	7,435 New	7,435 $2.08 Million
Q4 2024 Feb 13, 2025	SELL	$258.78 - $328.31 $506,432 - $642,502	-1,957 Reduced 58.04%	1,415 $368,000
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $1.66 Million - $1.81 Million	-5,354 Reduced 61.36%	3,372 $1.09 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $2.02 Million - $2.46 Million	-7,692 Reduced 46.85%	8,726 $2.73 Million

Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $34.4 Million - $41.6 Million	-128,065 Reduced 88.64%	16,418 $4.67 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $29.9 Million - $33.7 Million	116,758 Added 421.13%	144,483 $41.6 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $30.3 Million - $37.6 Million	-138,503 Reduced 83.32%	27,725 $7.45 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $393,185 - $464,933	1,835 Added 1.12%	166,228 $36.9 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $34.4 Million - $42 Million	152,566 Added 1289.98%	164,393 $39.7 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $362,554 - $460,668	1,583 Added 15.45%	11,827 $3.11 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $10 Million - $11.3 Million	-44,542 Reduced 81.3%	10,244 $2.31 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $91,822 - $102,182	398 Added 0.73%	54,786 $13.3 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $6.25 Million - $6.92 Million	28,510 Added 110.17%	54,388 $13.2 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $2.38 Million - $2.72 Million	-11,964 Reduced 31.62%	25,878 $5.82 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1.86 Million - $2.17 Million	8,743 Added 30.05%	37,842 $8.05 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $6.55 Million - $7.27 Million	28,049 Added 2671.33%	29,099 $7.09 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1.59 Million - $1.85 Million	-7,150 Reduced 87.2%	1,050 $261,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $11.7 Million - $14 Million	-54,299 Reduced 86.88%	8,200 $1.89 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $7.88 Million - $9.21 Million	46,512 Added 290.94%	62,499 $10.7 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $7.31 Million - $8.16 Million	-43,286 Reduced 73.03%	15,987 $2.78 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $9.92 Million - $11.3 Million	59,273	59,273 $11.1 Million

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account